The discovery offers hope for 4,000 women diagnosed per year with HER2-positive breast cancer, who do not respond well to the current treatment, Herceptin.
from Health | Mail Online http://ift.tt/1o5Pv7j
via dailymail
from Health | Mail Online http://ift.tt/1o5Pv7j
via dailymail
No comments:
Post a Comment